Home > Publications

Publications 2015 - 2009



  1. Cox HS, Furin JJ, Mitnick CD, Cox V, Goemaere E. The need to accelerate access to new drugs for multidrug-resistant tuberculosis. Bulletin of the World Health Organisation.  2015 93 (7):491-497
  2. Cox HS, Daniels JF, Muller O, Nicol MP, Cox V, van Cutsem G, Moyo S, De Azevedo V, Hughes J.  Impact of decentralized care and the Xpert MTB/RIF test on rifampicin-resistant tuberculosis treatment initiation in Khayelitsha, South Africa.  Open Forum Infectious Diseases. 2015 2(1)
  3.  Ramma L, Cox H, Wilkinson L, Foster N, Cunnama L, Vassall A, Sinanovic E.Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis. 2015 Dec;19(12):1513-9.
  4. Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect Dis. 2015 Oct;15(10):1131
  5. Sizulu Moyo.  Cox HS, Hughes J, Daniels J, Synman L, De azevedo V, Shroufi A, Cox V, Van Cutsem G.   Loss from treatment for drug resistant tuberculosis: Risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa. 2015  PLOS ONE 2015. 10(3):e0118919
  6. Furin J, Harausz E, Zimetbaum P, Cox H. In reply. QTc prolongation and delamanid: access and safety. Int J Tuberc Lung Dis. 2015 Oct;19(10):1262-3. 
  7. Kranzer K, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F. A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. Thorax. 2015 Nov;70(11):1070-7. 
  8. Forbes S, Stafford S, Coope G, Heffron H, Real K, Newman R, Davenport R,Barnes M, Grosse J, Cox H. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models. Diabetes. 2015 Nov;64(11):3763-71. 9.       Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP,Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, Sinanovic E, Cox HS, Dye C, Grant AD, Fielding KL. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health. 2015 Aug;3(8):e450-7.
  9. Cox H, Ramma L, Wilkinson L, Azevedo V, Sinanovic E. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa. Trop Med Int Health. 2015 Oct;20(10):1337-45.
  10. von Mollendor C, von Gottber A, Tempia S, Meiring S, de Gouveia L, Quan V, Lengana S, Venant T, du Plessis N, Eley B, Finlayson H, Reubenson G, Moshe M, O’Brien KL, Klugmen KP, Whitney CG, Cohen C, GREMS-SA.  Increased risk for and mortality from invasive pneumococcal disease in HIV-Exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clinical Infectious Diseases. 2015 60(9): 1346-56
  11. Gardner-Lubbe S, Dube FS.  Visualisationof quadratic discriminant analysis and its application in exploration of microbial interactins.  BioData Mining 2015 8:8
  12. Lawn SD, Nicol MP, Corbett EL. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. Lancet Infect Dis. 2015 Jan;15(1):17-8.
  13. Lawn SD, Nicol MP.  Dead or alive: can viability staining predict response to tuberculosis treatment: Clinical Infectious Diseases.  2015 60(8): 1196-1198
  14. le Roux DM, Myer L, Nicol MP, Zar HJ. Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study. Lancet Glob Health. 2015 Feb;3(2):e95-e103.
  15. Wilkinson KA, Walker NF, Meintjes G, Deffur A, Nicol MP, Skolimowska KH, Matthews K, Tadokera R, Seldon R, Maartens G, Rangaka MX, Besra GS, Wilkinson RJ. Cytotoxic Mediators in Paradoxical HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome. J Immunol. 2015 Feb 15;194(4):1748-54.
  16. Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, McCarthy K, Churchyard G, Cox H. Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis. 2015 Feb;19(2):172-8.
  17. Narrandes NC, Machowski E, Mizrahi V, Kana BD. Cleavage of the moaX –encoded fused molybdopterin synthase from Mycobacterium tuberculosis is necessary for activity. BMC Microbiol. 2015 Feb 6;15(1):22. [Epub ahead of print]
  18. Singh V, Brecik M, Mukherjee R, Evans JC, Svetlíková Z, Blaško J, Surade S, Blackburn J, Warner DF, Mikušová K, Mizrahi V. The complex mechanism of antimycobacterial action of 5-fluorouracil. Chem Biol. 2015 Jan 22;22(1):63-75.
  19. Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends Microbiol. 2015 Jan;23(1):14-21.
  20. Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP.  Investigation the early-life determinants of illness in Africa: the Drakenstein child health study.  Thorax 2015 70:592-594
  21. Manenzhe RI, Zar HJ, Nicol MP, Kaba M.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.  Journal of Antimicrobial Chemotherapy 2015 70:23-40
  22. Abdulgader SM, Shittu AO, Nicol MP, Kaba M.  Molecular epidemiology of methicillin-resistant staphylococcus aureus in Africa : a systematic review.  Frontiers in Microbiology.  2015 6:348
  23. Dube FS, van Mens SP, Robberts L, Wolter N, Nicol P, Mafofo J, Africa S, Zar HJ, Nicol MP.  Comparison of a real-time multiplex PCR and sequetyping assay for pneumococcal serotyping.  PLOS ONE. 2015 3:10(9): e0137349
  24. Williams MJ, Shanley CA, Zilavy A, Peixoto B, Manca C, Kaplan G, Orme IM, Mizrahi V, Kana BD. Bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs. Infect Immun. 2015 83(2):544-50
  25. Lessem E, Cox H, Daniels C, Furin J, McKenna L, Mitnick  CD, Mosidi T, Reed C, Seaworth   B, Stillo J, Tisile P, von Delft D.  Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives.  International Journal of Infectious Diseases 2015 (32)56–60.
  26. Koch A, Mizrahi V, Warner DF.  The physiological consequences of bacterial drug resistance what can we learn from rifampicin? Emerging Microbes and Infection. 2015 3:e17
  27. Harauz E, Cox H, Rich M, Mitnick CD, Zimetbaum P, Furin J.  QTc prolongation and treatment of multidrug-resistant tuberculosis.  Int J Tuberc Lung Dis 2015 19(4):385-391
  28. Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum M , Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć  E, Ballif M, Barletta F, Peter Beck H, Barry III CE,  Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S,  Hanekom M, Hoffner S,  Jiao W, Kalon S, Kohl TA, Kontsevaya  I, Lillebæk T,  Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng L, Stakenas P, Toit K, Varaine F, Vukovic  D, Wahl C, Warren R, Supply P, Niemann S, Wirth T.   Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nature Genetics.  2015 47(3):242-9
  29. Moyo, S., Furin, J.J., Hughes, J., Daniels, J., Snyman, L., Muller, O., Cox, V., Shroufi, A., Cox, H. Outcomes in adolescents undergoing treatment for drug-resistant tuberculosis in Cape Town, South Africa, 2008-2013, Archives of Pediatric Infectious Diseases, 3(1) e17934, 2015
  30. Ndumbe PM, Uthman OA, Nicol MP, Hussey GD, Mayosi BM, Wiysonge CS. Increasing the value of health research in the WHO African Region beyond 2015 - reflecting on the past, celebrating the present, and building the future: a bibliometric analysis. BMJ Open. 2015 5:e006340
  31. McKay R, Bamford C.  Community- versus healthcare-acquired bloodstream infections at Groote Schuur Hospital, Cape Town, South Africa. South African Medicines Journal. 2015105(5): 363-9
  32. Kulin B, Meggersee R, D’Alton J, Galvao B, Rajabally N, Whitelaw A, Bamford C, Reid SJ, Abratt VR.Prevalence of gastrointestinal pathogenic bacteria in patients with diarrhoea attending Groote Schuur Hospital, Cape Town, South Africa. South African Medicines Journal.  2015 105(2): 121-125
  33.  Frigati L, Maskew M, Workman L, Munro J, Andronikou S, Nicol MP, Zar HJ.  Clinical Predictors of Culture-confirmed Pulmonary Tuberculosis in Children in a High Tuberculosis and HIV Prevalence Area. Pediatr Infect Dis J. 2015 Sep;34(9):e206-10.
  34.  Lawn SD, Kerkhoff AD, Burton R, Schutz C, van Wyk G, Vogt M, Pahlana P, Nicol MP, Meintjes G. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa. BMC Med. 2015 Aug 14;13:192.
  35.  Nicol MP, Gnanashanmugam D, Browning R, Click ES, Cuevas LE, Detjen A, Graham  SM, Levin M, Makhene M, Nahid P, Perez-Velez CM, Reither K, Song R, Spiegel HM, Worrell C, Zar HJ, Walzl G. A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S164-72.
  36.  Zar HJ, Workman LJ, Little F, Nicol MP. Diagnosis of Pulmonary Tuberculosis in Children: Assessment of the 2012 National Institutes of Health Expert Consensus Criteria. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S173-8.
  37.  Lawn SD, Nicol MP. Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment? Clin Infect Dis. 2015 Apr 15;60(8):1196-8
  38. Gqunta Km van Wyk J, Ekermans P, Bamford C, Moodley C, Govender S.  First report of an IMI-2 carbapenemase-producing Enterobacter asburiae clinical isolate in South Africa.  2015 30(1): 34-35.
  39.  Kullin B, Meggersee R, D'Alton J, Galvao B, Rajabally N, Whitelaw A, Bamford C, Reid SJ, Abratt VR. Prevalence of gastrointestinal pathogenic bacteria in patients with diarrhoea attending Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J. 2015 Jan 5;105(2):121-5.
  40.  McKay R, Bamford C. Community- versus healthcare-acquired bloodstream infections at Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J. 2015 Apr 6;105(5):363-9
  41.  Raban MS, Bamford C, Joolay Y, Harrison MC. Impact of an educational intervention and clinical performance dashboard on neonatal bloodstream infections. S Afr Med J. 2015 Sep 21;105(7):564-6.
  42.  von Mollendorf C, von Gottberg A, Tempia S, Meiring S, de Gouveia L, Quan V, Lengana S, Avenant T, du Plessis N, Eley B, Finlayson H, Reubenson G, Moshe M, O'Brien KL, Klugman KP, Whitney CG, Cohen C; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis. 2015 May 1;60(9):1346-56.
  43. Moodley C, Reid SH, Abratt VR.  Molecular characterisation of ABC-type multidrug efflux systems in Bifidobacterium longum.  Anaerobe.  2015 32:63-69
  44. Oberhoster PJ, Jappie S, Cheng PH, Botha AM, Mathews MW.  First report of an anabaena bory strain containing microcysti-LR in a freshwater. 2015  40(1) :21-36
  45. Moyo, S., Furin, J.J., Hughes, J., Daniels, J., Snyman, L., Muller, O., Cox, V., Shroufi, A., Cox, H. Outcomes in adolescents undergoing treatment for drug-resistant tuberculosis in Cape Town, South Africa 2008-2013.  Archives of Pediatric Infectious Diseases 2015: 3(1) e1793
  46. Evans JC, Mizrahi V. The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis. Front Microbiol. 2015 Aug 4;6:812.
  47. Gopinath K, Warner DF, Mizrahi V. Targeted gene knockout and essentiality testing by homologous recombination. Methods Mol Biol. 2015;1285:131-49
  48. Candice Sde M, Feng TS, van der Westhuyzen R, Gessner RK, Street LJ, Morgans GL, Warner DF, Moosa A, Naran K, Lawrence N, Boshoff HI, Barry CE 3rd, Harris CJ,Gordon R, Chibale K. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization. Bioorg Med Chem. 2015 Nov 15;23(22):7240-50. 
  49. Rajabally N, Kullin B, Ebrahim K, Brock T, Weintraub A, Whitelaw A, Bamford C,Watermeyer G, Thomson S, Abratt V, Reid S. A comparison of Clostridium difficile diagnostic methods for identification of local strains in a South African centre. J Med Microbiol. 2016 Feb 9.
  50. Perovic O, Iyaloo S, Kularatne R, Lowman W, Bosman N, Wadula J, Seetharam S,Duse A, Mbelle N, Bamford C, Dawood H, Mahabeer Y, Bhola P, Abrahams S,Singh-Moodley A. Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology. PLoS One. 2015 Dec 31;10(12):e0145429



  1.  Lawn SD, Nicol MP. Dead or Alive: Can Viability Staining Predict Response to Tuberculosis Treatment? Clin Infect Dis. 2014 Dec 23.
  2.  Coetzee L, Nicol MP, Jacobson R, Schubert PT, van Helden PD, Warren RM, Wright CA. Rapid diagnosis of pediatric mycobacterial lymphadenitis using fine needle aspiration biopsy. Pediatr Infect Dis J. 2014 Sep;33(9):893-6.
  3.  Zetola NM, Shin SS, Tumedi KA, Moeti K, Ncube R, Nicol M, Collman RG, Klausner JD, Modongo C. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol. 2014 Jul;52(7):2422-9.
  4.  Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP. Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study. Thorax.   16.
  5.  Houben RM, Dowdy DW, Vassall A, Cohen T, Nicol MP, Granich RM, Shea JE, Eckhoff P, Dye C, Kimerling ME, White RG; TB MAC TB-HIV meeting participants. How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis. 2014 May;18(5):509-14.
  6.  Nicol MP, Allen V, Workman L, Isaacs W, Munro J, Pienaar S, Black F, Adonis L, Zemanay W, Ghebrekristos Y, Zar HJ. Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health.  2014 May;2(5):e278-84.
  7.  Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BA, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):270-9.
  8.  Osman M, Simpson JA, Caldwell J, Bosman M, Nicol MP. GeneXpert MTB/RIF version G4 for identification of rifampin-resistant tuberculosis in a programmatic  setting. J Clin Microbiol. 2014 Feb;52(2):635-7.
  9.  Planting NS, Visser GL, Nicol MP, Workman L, Isaacs W, Zar HJ. Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis. 2014 Jan;18(1):8-12
  10.  Cox HS, Mbhele S, Mohess N, Whitelaw A, Muller O, Zemanay W, Little F, Azevedo V, Simpson J, Boehme CC, Nicol MP. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial. PLoS Med. 2014 Nov 25;11(11):e1001760.
  11.  Cox H, van Cutsem G, Cox V. Better treatment of XDR tuberculosis needed in South Africa. Lancet. 2014 Aug 16;384(9943):581-2.
  12.  Cox HS. The benefits and risks of mathematical modelling in tuberculosis. Int J Tuberc Lung Dis. 2014 May;18(5):507.  
  13.  Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, Boulle A, Goemaere E, van Cutsem G. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. Int J Tuberc Lung Dis. 2014 Apr;18(4):441-8.
  14.  Cox H, Ford N.  The scourge of tuberculosis and anti-tuberculosis drug resistance in Easter Europe.  Public Health Action. 2014 4(3): S1-S2.
  15.  von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, Madhi SA, Zell ER, Verani JR, O'Brien KL, Whitney CG, Klugman KP, Cohen C; GERMS-SA Investigators. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014 Nov 13;371(20):1889-99.
  16.  Perovic O, Singh-Moodley A, Dusé A, Bamford C, Elliott G, Swe-Han KS, Kularatne R, Lowman W, Whitelaw A, Nana T, Wadula J, Lekalakala R, Saif A, Fortuin De-Smit M, Marais E. National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010 2012. S Afr Med J. 2014 Jun 19;104(8):563-8.
  17. Kift EV, Maartens G, Bamford C. Systematic review of the evidence for rational dosing of colistin. S Afr Med J. 2014 Mar;104(3):183-6.
  18. Lowman W, Bamford C, Govind C, Swe Swe Han K, Kularatne R, Senekal M, Brink A, Moodley P, Thomas J, Smit J, Perovic O.  The SASCM CRE-WG: consensus statement and working guidelines for the screening and laboratory detection of carbapenemase-producing Enterobacteriaceae.  South Afr Journal of Infectious Disease 2014 29(1): 5-11
  19. Lewis DA. Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen? Expert Rev Anti Infect Ther. 2014 Jun;12(6):687-96.
  20. Lewis DA. Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis. 2014 Feb;27(1):62-7.
  21. Warner DF. Mycobacterium tuberculosis Metabolism. Cold Spring Harb Perspect Med. 2014 Dec 11.
  22. Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends Microbiol. 2015 Jan;23(1):14-21.
  23. Warner DF, Mizrahi V. Translating genomics research into control of tuberculosis: lessons learned and future prospects. Genome Biol. 2014 Nov 7;15(11):514
  24. Warner DF, Mizrahi V. Shortening treatment for tuberculosis--to basics. N Engl J Med. 2014 Oct 23;371(17):1642-3.
  25. Singh K, Kumar M, Pavadai E, Naran K, Warner DF, Ruminski PG, Chibale K.  Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c. Bioorg Med Chem Lett. 2014 Jul 15;24(14):2985-90.
  26. McGrath M, Gey van Pittius NC, van Helden PD, Warren RM, Warner DF. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2014 Feb;69(2):292-302.
  27. Warner DF, Mizrahi V. Translating genomics research into control of tuberculosis: lessons learned and future prospects. Genome Biol. 2014 Nov 7;15(11):514.
  28. Arora K, Ochoa-Montaño B, Tsang PS, Blundell TL, Dawes SS, Mizrahi V, Bayliss T, Mackenzie CJ, Cleghorn LA, Ray PC, Wyatt PG, Uh E, Lee J, Barry CE 3rd, Boshoff HI. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014 Nov;58(11):6962-5.
  29. Xu Z, Yin W, Martinelli LK, Evans J, Chen J, Yu Y, Wilson DJ, Mizrahi V, Qiao C, Aldrich CC. Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. Bioorg Med Chem. 2014 Mar 1;22(5):1726-35.
  30. Williams M, Mizrahi V, Kana BD. Molybdenum cofactor: a key component of Mycobacterium tuberculosis pathogenesis? Crit Rev Microbiol. 2014 Feb;40(1):18-29.

Publications 2009 - 2013

  1. Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD.  A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the expanded program on immunization in 1974.  BMC Medicine 2013: 11(66).
  2. Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, Boehme CC, Nicol MP. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis 2013, 13: 407
  3. Nicol MP, Whitelaw A, Stevens W. Using Xpert MTB/RIF. Current Respiratory Medicine Reviews 2013 9: 187-192
  4. Zar HJ, Workman L, Isaacs W, Dheda K, Zemanay W, Nicol MP. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting using Xpert MTB/RIF on respiratory specimens: a prospective study. Lancet Global Health 2013 1(2): e97-e104
  5. Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial. Trials 2013; 14:170
  6. Claassen S, du Toit E, Zar HJ, Nicol MP. An comparison of the efficiency of five different commercial DNA extraction kits for extraction of DNA from stool samples. J Microbiol Methods 2013 Aug;94(2):103-10.
  7. Dube F, Kaba M, Whittaker E, Zar HJ, Nicol MP. Detection of Streptococcus pneumoniae from different types of nasopharyngeal swabs in children. PLoS ONE 2013 Jun 26;8(6):e68097.
  8. Nicol MP, Spiers K, Workman L, Isaacs W, Munro J, Black F, Zemanay W, Zar HJ. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 2013 57:e18-21
  9. Ling DI, Nicol MP, Pai M, Pienaar S, Dendukuri N, Zar HJ. Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis. Thorax 2013 68:880-6
  10. Mudau M, Jacobson R, Minenza N, Kuonza L, Morris V, Engelbrecht H, Nicol MP, Bamford C.Outbreak of Multi-Drug Resistant in Bloodstream Infection in the Haematology Unit of a South African Academic Hospital. PLoS ONE 2013; 8:e55985
  11. Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tub Lung Dis 2013; 17:552-8
  12. Loerger, TR, O’Malley T, Liao R, Guinn KM, Hickey MJ, Mohaideen N, Murphy KC, Boshoff HIM, Mizrahi V, Rubin EJ, Sassetti CM, Barry III CE, Sherman DR, Parish T, Sacchettini JC.  Identification of new drug targets and resistance mechanisms in mycobacterium tuberculosis.  PLos One 2013; 8 (9) e75245
  13. Moodley MV, Oliver SP, Shankland I, Elisha BG.  Evaluation of five susceptibility test methods for detection of tobramycin resistance in a cluster of epidemiologically realated acinetobacter baumannii isolates.  Journal of Clinical Microbiology 2013; 51(8) 2535-2540.
  14. Von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, Crowther-Gibson P, Madhi SA, Whitney CG, Klugman KP.  Epidemiology of invasive pneumococcaldisease in the pre-conjugate vaccine era: South Africa, 2003-2008.  Vaccine 2013 31: 4200-4208.
  15. Gopinath K, Venclova C, loerger TR, Sacchettini JC, McKinney JD, Mizrahi V, Warner DF.  A vitamin B12 transporter in mycobacterium tuberculosis.  Open Biology 2013 3: 120175
  16. Singh J, Sankar MM, Kumar S, Gopinath K, Singh N, Mani K, Singh S.  Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a Peri-Urban population of South Delhi, India.  PLos One 2013 8(7): e69730
  17. Nglazi MD, Bekker L-G, Wood R, Hussey GD, Wiysonge CS.  Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review.  BMC Infectious diseases 2013 13:566
  18. Li Y, de Kock C, Smith PJ, Guzgay H, Hendricks DT, Naran K, Mizrahi V, Warner DF, Chibale K, Smith GS.  Synthesis, characterization and Pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial and ntimycobacterial agents.  American Chemical Society Organometallics 2013 32: 141-150.
  19. Tukulula M, Sharma R, Meurillon M, Mahajan A, Naran K, Warner D, Huang J, Mekonnen B, Chibale K.  Synthesis and antiplasmodial and antimycobacterial evaluation of new nitroimidazole and nitroimidazooxazine derivatives.  ACS Medicinal Chemistry Letters 2013 4: 128-131.
  20. Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS.  Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS (Review).  2013 3
  21. Lewis DA, Marsh K, Radebe F, Maseko V, Hughes G.  Trends and associations of trichomonas viginalis infection in men and women with genital discharge syndromes in Johannesburg, South Africa.  Sexual transimitted Infection 2013 89:523-527
  22. Muller EE, Magooa MP, Lewis DA.  Generic characterization of herpes simplex virus type 2 UL23 thymidine kinase in Johannesburg, South Africa. Journal of Antiviral and Antiretrovirals  2013 5(4): 080-084
  23. Lewis DA, Gumede LYE, van der Hoven LA, de Gita GN, de Kock EJE, de Lange T, Maseko V, Kekana V, smuts FP, Perovic O.  Antimicrobial susceptibility of organisms causing cimmunity-acquired urinary tract infections in Gauteng Province, South Africa.  SAMJ 2013 103 (6) 377-381
  24. Magooa MP, Muller EE, Gumede L, Lewis DA.  Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimen from men using a real-time PCR assay 2013. 42: 36-67
  25. Willis N, Hill S, Kaufman J, Lewin S, Kis-Rigo J, De Castro Freire SB, Bosch-Capblanch X, Glenton C, Lin V, Robinson P, Wiysonge C.  “Commuincate to vaccinate”: the development of a taxomomy of communication interventions to improve routine childhood vaccination 2013.  13: 23
  26. Lewis DA, Sriruttan C, Muller EE, Goparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M.  Phenotypic and gentic characterization of the first two cases of extended-spectrum-cepholosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure 2013.  Journal of Antimicrobial Chemotherapy 41:12671270.
  27. William M, Mizrahi V, Kana BD.  Molybedum cofactor: a key component of mycobacterium tuberculosis pathogenesis 2013. Critical Reviews in Microbiology
  28. Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, Richards GA, Feldman C, Nutt L, van Greune J, Deetlefs JD, Swart K, Lesley D, Poirel L, Nordmann P.  Emergence of OXA-48 and OXA-181 carbapenemases among enterobactiraceae in South Africa and evidence of In Vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract 2013.  Journal of Clinical Microbiology 51: 369-372.
  29. Machingaidze S, Wiysonge CS, Hussey GD.  Strengthening the expanded programme on Immunization in Africa: Looking beyond 2012. Plos Medicine 2013 March 10 (3): 1-5
  30. Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD. A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the expanded program on immunization in 1974. BMC Medicine 2013: 11(66).
  31. Griffin JE, Pandey AK, Gilmore SA, Mizrahi V, McKinney JD, Bertozzi CR, Sassetti CM. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol. 2012 Feb 24;19(2):218-27.
  32. Warner DFMizrahi V. Approaches to target identification and validation for tuberculosis drug discovery: a UCT perspective. S Afr Med J. 2012 Mar 2;102(6):457-60..
  33. Warner DFMizrahi V. A pseudokinase debut at the mycobacterial cell wall. Sci Signal. 2012 Jan 24;5(208):pe3. Review..
  34. Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, Allen V, Boehme CC, Zemanay W, Nicol MP. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012 Jul 2.
  35. Jacobson RK, Minenza N, Nicol M, Bamford C. VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J Antimicrob Chemother. 2012 Jul;67(7):1797-8.
  36. Mendelson M, Whitelaw A, Nicol M, Brink A. Wake up South Africa! The antibiotic 'horse' has bolted. S Afr Med J. 2012 May 10;102(7):607-8.
  37. Zar HJ, Eley B, Nicol MP, Figaji A, Hawkridge A. Advances in childhood tuberculosis - contributions from the University of Cape Town. S Afr Med J. 2012 Mar 2;102(6):518-21.
  38. Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, McCarthy KM, Whitelaw AC, Govender NP; for the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA). A comparison of paediatric- and adult-onset cryptococcosis detected through population-based surveillance in South Africa, 2005-2007. AIDS. 2012 Jun 27.
  39. Jansen van Rensburg MJWhitelaw ACElisha BG. Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa. BMC Microbiol. 2012 Mar 26;12:46.
  40. Keddy KH, Sooka A, Crowther-Gibson P, Quan V, Meiring S, Cohen C, Nana T, Sriruttan C, Seetharam S, Hoosen A, Naicker P, Elliott E, Haffejee S, Whitelaw A, Klugman KP; Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA). Systemic shigellosis in South Africa. Clin Infect Dis. 2012 May;54(10):1448-54. Epub 2012 Apr 3.
  41. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. Characteristics and early outcomes of patients with Xpert® MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis. 2012 Apr;54(8):1071-9.
  42. Owen EP, Leisegang F, Whitelaw A, Simpson J, Baker S, Würzner R, Potter P, Orren A. Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa. S Afr Med J. 2012 May 23;102(6):525-7.
  43. Epstein D, Mistry K, Whitelaw A, Watermeyer G, Pettengell KE. The effect of physiological concentrations of bile acids on in vitro growth of Mycobacterium tuberculosis. S Afr Med J. 2012 May 23;102(6):522-4.
  44. Obiero J, Mwethera PG, Hussey GDWiysonge CS. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis. 2012 Nov 6;12:289: 1-9.
  45. Akl EA, Kennedy C, Konda K, Caceres CF, Horvath T, Ayala G, Doupe A, Gerbase A, Wiysonge CS, Segura ER, Schünemann HJ, Lo YR. Using GRADE methodology for the development of public health guidelines for the prevention and treatment of HIV and other STIs among men who have sex with men and transgender people. BMC Public Health. 2012 May 28;12:386.
  46. Wiysonge CS, Ngcobo NJ, Jeena PM, Madhi SA, Schoub BD, Hawkridge A, Shey MS, Hussey GD. Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health. 2012 Jul 31;12:578.
  47. Syed FF, Ntsekhe M, Wiysonge CS, Badri M, Oh JK, Mayosi BM. Atrial fibrillation as a consequence of tuberculous pericardial effusion. Int J Cardiol. 2012 Jun 28;158(1):152-4.
  48. Wiysonge CS., Uthman OA., Ndumbe PM, Hussey GD. Individual and Contextual Factors Associated with Low Childhood Immunisation Coverage in Sub-Saharan Africa: A Multilevel Analysis. 2012 May:7(5): e37905
  49. Crowther-Gibson P, Cohen C, Klugman KP, de Gouveia L, von Gotteberg A, GERMS-SA. Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence in the prevaccine era from 2003 to 2008. Antimicrobial agents and chemotherapy. 2012 Oct 56(10): 5088-5095.
  50. von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, du Plessis M, Madhi SA, Klugman KP, GERMS-SA. Invasive disease due to haemophilus influenza serotype b ten years after routine vaccination, South Africa 2003-2009.  Vaccine. 2012: 30: 565-571.
  51. Sarkar R, Lenders L, Wilkinson KA, Wilkinson RJ, Nicol MP. Modern lineage of mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocye-derived macrophages. Plos one. 2012 August 7 (8) e431170.
  52. Coetzee E, Whitelaw A, Kahn D, Rode H. The use of topical un-buffed sodium hypochlorite in the management of burn wound infection. 2012. Burns 38: 529-533
  53. Abrahams GL, Kumar A, Savvi S, Hung AW, Wen S, Abell C, Barry III CE, Sherman DR, Boshof HIM, Mizrahi V. Pathway selective sensitization of mycobacterium tuberculosis for target based whole cell screening. Chemistry and Biology. 2012. July 27: 19 844-854.
  54. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. International Journal of Tuberculosis and Lung Disease. 2011 15 (6):770-775. CA Wiseman, H S Schaaf, MF Cotton, RP Gie, T Jennings, A Whitelaw, P. Roux, A C Hesseling.
  55. Guideline for the optimal use of blood cultures. SAMJ December 2010. 10 (12) 839-843. Ntobeko Ntusi, Lindsey Aubin, Stephen OliverAndrew Whitelaw, Marc Mendelson.
  56. Comparative cost and performance of LED-microscopy in HIV-TB co-infected patients. ERJ Express. Published on June 9, 2011 (in press). A Whitelaw, J Peters, H Sohn, D Viljoen, G Theron, M Badri, Virginia Davids, M Pai, K Dheda
  57. Prevalence and outcome of cytomegalovirus-associated pneumonia in relation to human immunodeficiency virus infection. Pediatric Infectious Disease Journal 2011:30 (5) 413-417. M Zampoli, B Morrow, N-Y Hsiao, A Whitelaw, and HJ Zar.
  58. Feasibility, diagnostic accuracy, and eff ectiveness of decentralised use of the Xpert® MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011 :1495-505. CC Boehme, MP Nicol, P Nabeta, JS Michael, E Gotuzzo, R Tahirli, MT Gler, R Blakemore, W Worodria, C Gray, L Huang, T Caceres, R Mehdiyev, L Raymond, A Whitelaw, K Sagadevan, H Alexander, H Albert, F Cobelens, H Cox, D Alland, MD Perkins.
  59. Evaluation of the Xpert® MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. AJRCCM Articles in Press. Published on April 14, 2011:10 (30). G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, R Dawson, A Whitelaw, M Hoelscher, S Sharma, M Pai, R Warren, K Dheda.
  60. Xpert® MTB/RIF for the rapid diagnosis of tuberculous lymphadenitis from Fine Needle Aspiration biopsy specimens. J Clin Microbiol.2011 Aug 31. LJ Ligthelm, MPNicol, KG Hoek, R Jacobson, PD van Helden, BJ Marais, RM Warren, CA Wright. (in press)
  61. A Multi-Site Assessment of the Quantitative Capabilities of the Xpert® MTB/RIF Assay. Am J Respir Crit Care Med. 2011 Aug 11. C Rodrigues, CC Boehme, MD Perkins, D Alland, Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, Ruesch-Gerdes S, Leisegang F, Zamudio C,
  62. Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert® MTB/RIF Assay: A Prospective Study. PLoS Med. 2011 Jul;8(7):e1001067. Epub 2011 Jul 26. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R.
  63. Accuracy of the Xpert® MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis. 2011 Jul 15. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ.
  64. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev. 2011 Mar;12(1):16-21. Epub 2010 Oct 16.Nicol MPZar HJ. Review.
  65. Integrating TB and HIV services. SA J Epidemiol Infect. 2011; 26(2): 55-59. Whitelaw A.
  66. Global Antibiotic Resistance Partnership Situation Analysis: Antibiotic use and resistance in South Africa Part VII. Interventions. S Afr Med J. 2011; 101: 587-95.. Visser A, Moore DP, Whitelaw A, Lowman W, Kantor G, Hoosen A, Madhi S, Brink A, van den Bergh D, Devenish L, Moodley P, Apalata T, Duse AG, Gelband H.
  67. Bacteremia in Human Immunodeficiency Virus-infected Children in Cape Town, South Africa. Pediatr Infect Dis J. 2011; 30: 904-6. le Roux DM, Cotton MF, le Roux SM,Whitelaw A, Lombard CJ, Zar HJ.
  68. Part VII : Interventions. SAMJ. Visser A, Moore D.P., Whitelaw A., Lowman W, Kantor G.
  69. Analyses of Pediatric Isolates of Cryptococcus neoformans from South Africa. Antimicrobial agents and chemotherapy 2011: 2006-2611. Kathleen J Miglia, Nelesh P. Govender, Jenny Fossouw, Susan Meiring, Thomas G Mitchell, GERMS group (Andrew Whitelaw) in South Africa.
  70. Improved detection of pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study. Infectious Diseases 2011: 11: 329. Samuel CMWhitelaw A, Corcoran C, Morrow B, Hsiao N-Y, Zampoli M, Zar HJ.
  71. Rapid diagnosis of tuberculosis with the Xpert® MTB/RIF assay in high burden countries: a cost effectiveness analysis. Plos Medicine 2011: 8(11) e1001120. Vassal A, van Kampen S, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol M, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.
  72. Analyses of Pediatric isolated of Cryptococcus neoformans from South Africa. Journal of Clinical Microbiology 2011: 49(1):307. Miglia KJ, Govender NP, Rossouw J, Meiring S, Mitchell TG, GERMSA group (Andrew Whitelaw).
  73. Comparison of quatitative techniques including Xpert® MTB/RIF to evaluate mycobacterial burden. Plos One 2011: 6(12) e28815.  Van Zyl-Smit R, Binder A, Meldau R, Mishra H, Semple PL, Theron G, Peter J, Whitelaw A, Sharma SK, Warren R, Bateman ED, Dheda K.
  74. The dominant methicillin-resitant staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612. European Society of Clinical Microbiology and Infectious Diseases 2011:17(5):785-792. Jansen van Rensburg M, Madikane VE, Whitelaw A, Chachage M, Haffejee S, Elisha BG.
  75. Xpert® MBT/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiology 2011: 6(9) 1067-1082. Lawn SD, Nicol MP.
  76. Nicol MP. New developments in the laboratory diagnosis of tuberculosis.
    Continuing Medical Education. 2010 June
  77. Connell TG, Davies MA, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Beatty D, Nicol MP, Curtis N, Eley B. Reversion and conversion of M. tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children.
    BMC Infect. Dis. 2010, 10:138.
  78. Helen S.Cox, Cheryl McDermid, Virginia Azevedo, Odelia Muller, David Coetzee, John Simpson, Marinus Barnard, Gerrit Coetzee, Gilles van Cutsem, Eric Goemaere.Epidemic Levels of Drug Resistant Tuberculosis ( MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa. 
    PLoS ONE November 2010 Vol5 Issue 11 e13901
  79. Zar HJ, Connell T, Nicol MP. Diagnosis of pulmonary tuberculosis in children: new advances. 
    Expert Rev. Anti Infect. Ther. 2010 8(3), 277-288
  80. Nicol MP, Grobler LA. MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults. 
    Curr Opin Mol Ther. 2010 Feb;12(1):124-34.
  81. Wright CA, Bamford C, Prince Y, Vermaak A, Hoek KG, Marais BJ, Warren RM. Mycobacterial Transport medium for Fine Needle Aspiration Biopsies. 
    Archives of Disease in Childhood 2010; 95:48-50.
  82. D. Sissolak, C. Bamford, S. Mehtar. The potential to transmit Mycobacterium tuberculosis at a South African tertiary teaching hospital. 
    Int J Infect Dis 2010;5:e423-e428.
  83. Bamford CM, Taljaard J. Potential for nosocomial transmission of multi-drug resistant (MDR) tuberculosis in a South African tertiary hospital. 
    S Afr Med J 2010;100:438-441.
  84. Bamford CM, Goodway J, Hoffmann, R. Rapid identification and susceptibility testing of gram-negative bacilli from blood cultures using Vitek 2 system. 
    South African Journal of Epidemiology and Infection 2010;25:28 -31.
  85. Morrow BM, Hsaio NY, Zampoli M, Whitelaw A, Zar HJ. Pneumocystis Pneumonia in South African Children With and Without Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy. 
    Pediatr Infect Dis J. 2010 Jan 12
  86. Khutlang R, Krishnan S, Whitelaw A, Douglas TS. Automated detection of tuberculosis in Ziehl-Neelsen-stained sputum smears using two one-class classifiers. 
    J Microsc. 2010 Jan;237(1):96-102.
  87. Morrow BM, Whitelaw A, Zampoli M, Westwood AT (2010) Infection Control in Cystic Fibrosis: Recommendations for South African hospitals, clinics and social settings. 
    South African Respiratory Journal. 16 (1): 20 - 25.
  88. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. 
    PLoS One. 2010 Mar 24;5(3):e9848.
  89. Hanekom WA, Lawn SD, Dheda K, Whitelaw A.Tuberculosis research update. 
    Trop Med Int Health. 2010 Aug;15(8):981-9.
  90. Jansen van Rensburg MJ, Eliya Madikane V, Whitelaw A, Chachage M, Haffejee S, Gay Elisha B. The dominant methicillin-resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612. 
    Clin Microbiol Infect. 2010 Sep 20.
  91. Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, Kaplan G, McIntyre J, Wood R.
    Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. 
    Am J Respir Crit Care Med. 2010 Oct 15;182(8):1080-5
  92. Evans J, Segal H. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis
    J Antimicrob Chemother. 2010 May;65(5):897-900. Epub 2010 Feb 25.
  93. D'Souza DTB, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, Nicol M, Wilkinson RJ. High levels of Multidrug Resistant Tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an Urban metropolis (Mumbai) in Western India. 
    BMC Public Health. 2009 Jun 29;9:211
  94. Davies MA, Connell T, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Eley B, Beatty D, Curtis N and Nicol MP. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. 
    AIDS. 2009 May 15;23(8):961-9.
  95. Evans J, Stead M, Nicol, MP, Segal H. Rapid Genotypic Assays to Identify Drug-Resistant Mycobacterium tuberculosis in South Africa. 
    J Antimicrob Chemother. 2009 Jan;63(1):11-6.
  96. Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge A, Eley B, Wilkinson K, Wilkinson RJ, Hanekom WA, Beatty D, Hussey D. A comparison of T-SPOT.TB and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. 
    Pediatrics. 2009 Jan;123(1):38-43.
  97. Gounden R, Bamford C, van Zyl-Smit R, Cohen K, Maartens G. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. 
    BMC Infect.Dis. 2009 Mar 9;9:26.
  98. Wright CA, Hesseling AC, Bamford C, Burgess S, Warren R, Marais BJ. Fine needle aspiration biopsy - a first line diagnostic procedure in pediatric tuberculosis suspects with peripheral lymphadenopathy? 
    Int J Tuberc Lung Dis. 2009; 13:1373-1379.
  99. Hatherill M, Hawkridge T, Zar H, Whitelaw A, Tameris M, Workman L, Geiter L, Hanekom W, Hussey G. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? 
    Arch Dis Child 2009; 94: 195-201.
  100. Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, Roux P, Godfrey-Faussett P, Schaaf HS. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. 
    Clin Infect Dis 2009; 48: 108-114
  101. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, Symons G, Khalfey H, Carr I, Maredza A, Dawson R, Wainright H, Whitelaw A, Bateman E, Zumla A. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. 
    PLoS ONE 4(3): e4689. doi:10.1371/journal.pone.0004689
  102. Dheda K, van Zyl-Smit RN, Sechi LA, Badri M, Meldau R, Meldau S, Symons G, Semple L, Maredza A, Dawson R, Wainright H, Whitelaw A, Vallie Y, Raubenheimer P, Bateman ED, Zumla A..Utility of quantitative T cell responses versus unstimulated IFN-{gamma} for the diagnosis of pleural tuberculosis. 
    Eur Respir J. 2009 Apr 22
  103. Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, Govender N, Rosu V, Sechi LA, Maredza A, Semple PL, Whitelaw A, Wainright H, Badri M, Dawson R, Bateman ED, Zumla A. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis.  
    Thorax. 2009 Jul 9.
  104. Hesseling AC, Johnson LF, Jaspan H, Cotton MF, Whitelaw A, Schaaf HS, Fine PEM, Eley BS, Marais BJ, Nuttall J, N Beyers, Godfrey-Faussett P. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants.
    Bull WHO 2009;87:505-51
  105. Middelkoop K, Bekker L, Mathema B, Shashkina E, Kurepina N, Whitelaw A, Fallows D, Morrow C, Kreiswirth B, Kaplan G, Wood R. Molecular Epidemiology ofMycobacterium tuberculosis in a South African Community with High HIV Prevalence.
    J Infect Dis 2009; 200:1207-11
  106. Evans J, Stead MC, Nicol MP, Segal H. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. 
    J Antimicrob Chemother. 2009 Jan;63(1):11-6. Epub 2008 Oct 21.